Media.Player

A Strategy for Attenuated-live Vaccines for Bacterial Infections

技術優勢

• Prevents infection by stimulating patient immune system • Inexpensive, easy-to-grow bacterium • Simple to administer

詳細技術說明

A novel method to treat urinary tract infection using attenuated-live vaccines.#therapeutics #diseasemodel #vaccine

*Abstract

Urinary tract infections, either chronic or acute, are a frequent health problem in a variety of populations. Northwestern investigators have demonstrated that deletion of a certain gene from urinary-tract colonizing bacteria has resulted in a strain that promotes immune response when administered to mammalian subjects. The modified bacterium does not establish a persistent population in the bladder, but promotes cytokine secretion from urothelial cells. These bacteria represent a candidate material for a live-attenuated vaccine that could be used to protect against acute and recurrent urinary tract infections. Successful tests have been performed in a mouse model.

*Inventors

Anthony J. Schaeffer* David J. Klumpp Benjamin Billips

*Publications

Billips, B. Yaggie, R. Cashy, J. Schaeffer, A. Klumpp, D. (2009) A Live-Attenuated Vaccine for the Treatment of Urinary Tract Infection by Uropathogenic Escherichia Coli. The Journal of Infectious Diseases. 200(2): 263-272.

國家/地區

美國